NASDAQ:SIEN - Sientra Stock Price, Price Target & More

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

Sientra (NASDAQ:SIEN) announced its quarterly earnings data on Wednesday, May, 9th. The medical instruments supplier reported ($0.99) EPS for the quarter, missing the consensus estimate of ($0.84) by $0.15. The medical instruments supplier had revenue of $14.60 million for the quarter, compared to the consensus estimate of $14.49 million. Sientra had a negative net margin of 164.72% and a negative return on equity of 181.25%. Sientra's revenue for the quarter was up 95.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.61 earnings per share. View Sientra's Earnings History.

7 brokers have issued 12 month price targets for Sientra's stock. Their forecasts range from $12.00 to $19.00. On average, they anticipate Sientra's share price to reach $16.00 in the next year. View Analyst Ratings for Sientra.

Sientra saw a increase in short interest during the month of April. As of April 30th, there was short interest totalling 3,202,217 shares, an increase of 62.8% from the April 13th total of 1,966,788 shares. Based on an average daily volume of 700,192 shares, the days-to-cover ratio is presently 4.6 days. Currently, 23.0% of the shares of the company are short sold.

Some companies that are related to Sientra include Consort Medical (CSRMY), Invacare (IVC), RTI Surgical (RTIX), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), Rewalk Robotics (RWLK), NanoVibronix (NAOV), Helomics (AIPT), Allied Healthcare Products (AHPI), Bionik Laboratories (BNKL) and Avitar (AVTI).

Media headlines about SIEN stock have been trending somewhat positive this week, according to Accern. The research firm ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Sientra earned a coverage optimism score of 0.09 on Accern's scale. They also assigned news headlines about the medical instruments supplier an impact score of 46.10 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.

Sientra's stock is owned by many different of institutional and retail investors. Top institutional shareholders include ABINGWORTH LLP (8.90%), Cannell Capital LLC (5.89%), BlackRock Inc. (3.90%), Bamco Inc. NY (2.99%), Senzar Asset Management LLC (2.69%) and Millennium Management LLC (2.26%). Company insiders that own Sientra stock include Jeffrey M Nugent, Patrick F Williams, R Scott Greer and Timothy Haines. View Institutional Ownership Trends for Sientra.

SIEN stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, Cannell Capital LLC, Bamco Inc. NY, X Square Capital LLC, Senzar Asset Management LLC, Monarch Partners Asset Management LLC, Blair William & Co. IL and Quantum Capital Management. Company insiders that have bought Sientra stock in the last two years include Jeffrey M Nugent, Patrick F Williams, R Scott Greer and Timothy Haines. View Insider Buying and Selling for Sientra.

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of SIEN stock can currently be purchased for approximately $17.27.

Sientra has a market capitalization of $478.55 million and generates $36.54 million in revenue each year. The medical instruments supplier earns $-64,020,000.00 in net income (profit) each year or ($2.82) on an earnings per share basis. Sientra employs 200 workers across the globe.

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]